65 related articles for article (PubMed ID: 38723244)
1.
Zang Z; Yin Y; Liu C; Zhu Q; Huang X; Li H; Yang R
Epigenetics; 2024 Dec; 19(1):2352683. PubMed ID: 38723244
[TBL] [Abstract][Full Text] [Related]
2. Association of air pollution with postmenopausal breast cancer risk in UK Biobank.
Smotherman C; Sprague B; Datta S; Braithwaite D; Qin H; Yaghjyan L
Breast Cancer Res; 2023 Jul; 25(1):83. PubMed ID: 37443054
[TBL] [Abstract][Full Text] [Related]
3. How epigenetics impacts on human diseases.
Farsetti A; Illi B; Gaetano C
Eur J Intern Med; 2023 Aug; 114():15-22. PubMed ID: 37277249
[TBL] [Abstract][Full Text] [Related]
4. Screening and identification of prognostic genes associated with eosinophilic features of clear cell renal cell carcinoma.
Guo T; Jiang L; Wang T; Zhang J; Liu Y; Wang X; Zhang N; Chen S; Wang X
Heliyon; 2023 Jun; 9(6):e16479. PubMed ID: 37274638
[TBL] [Abstract][Full Text] [Related]
5. Clinical biomarker-based biological aging and risk of cancer in the UK Biobank.
Mak JKL; McMurran CE; Kuja-Halkola R; Hall P; Czene K; Jylhävä J; Hägg S
Br J Cancer; 2023 Jul; 129(1):94-103. PubMed ID: 37120669
[TBL] [Abstract][Full Text] [Related]
6. THOR is a targetable epigenetic biomarker with clinical implications in breast cancer.
Apolónio JD; Dias JS; Fernandes MT; Komosa M; Lipman T; Zhang CH; Leão R; Lee D; Nunes NM; Maia AT; Morera JL; Vicioso L; Tabori U; Castelo-Branco P
Clin Epigenetics; 2022 Dec; 14(1):178. PubMed ID: 36529814
[TBL] [Abstract][Full Text] [Related]
7. Gene body methylation in cancer: molecular mechanisms and clinical applications.
Wang Q; Xiong F; Wu G; Liu W; Chen J; Wang B; Chen Y
Clin Epigenetics; 2022 Nov; 14(1):154. PubMed ID: 36443876
[TBL] [Abstract][Full Text] [Related]
8. Classic and New Markers in Diagnostics and Classification of Breast Cancer.
Beňačka R; Szabóová D; Guľašová Z; Hertelyová Z; Radoňák J
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358862
[TBL] [Abstract][Full Text] [Related]
9. Marker assessments in ER-positive breast cancers: old markers, new applications?
Li JJX; Tse GM
Histopathology; 2023 Jan; 82(2):218-231. PubMed ID: 35945680
[TBL] [Abstract][Full Text] [Related]
10. Potential Prognostic Biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) Family Members in Breast Cancer.
Anuraga G; Wang WJ; Phan NN; An Ton NT; Ta HDK; Berenice Prayugo F; Minh Xuan DT; Ku SC; Wu YF; Andriani V; Athoillah M; Lee KH; Wang CY
J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834441
[TBL] [Abstract][Full Text] [Related]
11. RPTOR methylation in the peripheral blood and breast cancer in the Chinese population.
Yin Y; Lei S; Li L; Yang X; Yin Q; Xu T; Zhou W; Li H; Gu W; Ma F; Yang R; Zhang Z
Genes Genomics; 2022 Apr; 44(4):435-443. PubMed ID: 34767153
[TBL] [Abstract][Full Text] [Related]
12. Maternal vascular endothelial growth factor receptor and interleukin levels in pregnant women with twin-twin transfusion syndrome.
Anh ND; Thuong PH; Sim NT; Thao TTP; Anh LTL; Canh TTT; Dieu NV; Bac ND; Tong HV
Int J Med Sci; 2021; 18(14):3206-3213. PubMed ID: 34400890
[TBL] [Abstract][Full Text] [Related]
13. The association between RAPSN methylation in peripheral blood and breast cancer in the Chinese population.
Lei S; Li L; Yang X; Yin Q; Xu T; Zhou W; Gu W; Ma F; Yang R
J Hum Genet; 2021 Nov; 66(11):1069-1078. PubMed ID: 33958711
[TBL] [Abstract][Full Text] [Related]
14. Alterations of PTEN and SMAD4 methylation in diagnosis of breast cancer: implications of methyl II PCR assay.
Swellam M; Saad EA; Sabry S; Denewer A; Abdel Malak C; Abouzid A
J Genet Eng Biotechnol; 2021 Apr; 19(1):54. PubMed ID: 33825073
[TBL] [Abstract][Full Text] [Related]
15. Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer.
Freelander A; Brown LJ; Parker A; Segara D; Portman N; Lau B; Lim E
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33671468
[TBL] [Abstract][Full Text] [Related]
16. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
17. The Association Between Breast Cancer and Blood-Based Methylation of
Yin Q; Yang X; Li L; Xu T; Zhou W; Gu W; Ma F; Yang R
Front Genet; 2020; 11():977. PubMed ID: 33005177
[TBL] [Abstract][Full Text] [Related]
18. Clinical Significance of Expression Changes and Promoter Methylation of PLA2R1 in Tissues of Breast Cancer Patients.
Mitwally N; Yousef E; Abd Al Aziz A; Taha M
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751713
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
